Opus genetics phone number
WebOpus Genetics has an estimated revenue of <$1M and an estimate of less <10 employees. Overview Funding News & Insights. Opus Genetics is headquartered in Durham, North Carolina. Ben Yerxa is the CEO of Opus Genetics. Opus Genetics has raised a total of $28.5M in funding. WebJan 3, 2024 · Backed by Foundation Fighting Blindness’s venture arm, the Retinal Degeneration Fund, Opus Genetics combines unparalleled insight and commitment … Opus Genetics. Management Expertise, insight and commitment to deliver on … Opus’s most advanced program, OPGx-LCA5, is designed to address mutations … Opus Genetics. 8 Davis Drive. Suite 220. Durham, NC 27709. For collaborations or … Opus Genetics is a groundbreaking gene therapy company for inherited retinal … Opus is the first company conceived and launched by the Foundation Fighting … Opus’ unique approach. Validated science, well characterized material by … Opus Genetics, a patient-first gene therapy company developing treatments for … Brown et al., Human Molecular Genetics 2024 » View Presentation. May 17, 2024 : … January 3, 2024 : Genetic Engineering and Biotech News: Opus Genetics Acquires …
Opus genetics phone number
Did you know?
WebNov 30, 2024 · Opus Genetics announced an agreement to license its third preclinical program focused on an inherited retinal disease from Massachusetts Eye and Ear, Harvard Medical School’s ophthalmic... WebSep 23, 2024 · Opus Genetics, a Raleigh startup using gene therapy technology to treat blindness, raises $19 million from investors. The company’s technology was developed at the University of Pennsylvania.
WebOct 1, 2024 · Jean Bennett, MD, PhD, inventor and co-developer of Luxturna, the first FDA-approved gene therapy, now serves as scientific co-founder and sits on the board of Opus … WebOpus Genetics has 2 board members and advisors, including Rusty Kelley. Contacts Job Department Search Contacts... Joe Schachle Chief Operating Officer Executive Finance , Operations 1 email found Peter Ginsberg Co-Founder Executive Management 1 email found 1 phone number found Pete Candito Associate Director, CMC Project Management Director
WebDec 28, 2024 · December 28, 2024 Opus Genetics said it has acquired the rights to two preclinical-stage AAV-based gene therapy product candidates for inherited retinal diseases from Iveric Bio for $500,000 and a “high, single digit” ownership stake in Opus. Photo: Ben Yerxa, CEO of Opus Genetics WebOpus Genetics’ mission is to pave a proven, derisked, efficient path to the clinic for these urgently needed new therapies. Our programs address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). We continue to develop novel gene therapies for many of the other ...
WebOpus Genetics is headquartered in Durham, North Carolina. Ben Yerxa is the CEO of Opus Genetics. Opus Genetics has raised a total of $28.5M in funding. Opus Genetics has an …
WebSep 22, 2024 · The launch of Opus comes one day after Swiss pharma giant Novartis acquired Arctos Medical to strengthen its gene therapy-based options to treat different … north island mall port hardyWebSep 22, 2024 · RALEIGH, N.C., Sept. 22, 2024 (GLOBE NEWSWIRE) — The Retinal Degeneration Fund (RD Fund), the venture arm of the Foundation Fighting Blindness aimed at rapidly driving research toward preventions, treatments and cures for the entire spectrum of retinal degenerative diseases, today announced the launch of Opus Genetics, a patient … north island lodging naval baseWebDec 28, 2024 · Opus Genetics is a clinical-stage gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’ venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases. Its AAV-based … north island medical centerWebOpus Genetics Inc. Company Profile Durham, NC Competitors, Financials & Contacts - Dun & Bradstreet. Find company research, competitor information, contact details & financial … north island model a ford clubWebSep 22, 2024 · RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditions The Foundation in the News ... Phone: (800) 683-5555 6925 Oakland Mills Road, #701, Columbia, MD 21045. Donations can be mailed directly to: Foundation Fighting Blindness, P.O. Box 45740, Baltimore, MD 21297-5740 ... how to say i miss her in numbersWebAug 20, 2024 · The company offers adeno-associated virus (AAV)-based gene therapies and helps in tackling manufacturing obstacles standing in the way of treatments, helping people by providing access to treatments for blinding conditions efficiently. Contact Information Website opusgtx.com Ownership Status Privately Held (backing) Financing Status how to say i miss him in spanishWebSep 22, 2024 · The lead programs for Opus Genetics, which is based in North Carolina, are aimed at developing therapeutics that will address mutations in genes that cause different forms of Leber congenital amaurosis (LCA), a group of rare inherited retinal diseases that typically present in infancy and are characterized by degeneration of photoreceptors, the … north island maps new zealand